{"id":60995,"date":"2025-03-27T16:02:36","date_gmt":"2025-03-27T15:02:36","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/"},"modified":"2025-03-27T16:02:36","modified_gmt":"2025-03-27T15:02:36","slug":"harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/","title":{"rendered":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025"},"content":{"rendered":"
\n

\nCompany to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on March 28, 2025<\/b>\n<\/p>\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW<\/a>–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after the market close. The Company will also post its fourth quarter Letter to Stockholders to the \u201cInvestors\u201d section of its website, harrow.com<\/a>. Harrow will host a conference call and live webcast at 8:00 a.m. Eastern Time on Friday, March 28, 2025, to discuss the results and provide a business update.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nConference Call Information<\/b>\n<\/p>\n

\nParticipants can access the live conference call via webcast on the \u201cInvestors\u201d page of Harrow\u2019s website. To participate via telephone, please register in advance using this link<\/a>. Upon registration, all telephone participants will receive a confirmation email with detailed instructions, including a unique dial-in number and PIN, for accessing the call. A replay of the conference call and webcast will be archived on the Company\u2019s website for one year.\n<\/p>\n

\nAbout Harrow<\/b>\n<\/p>\n

\nHarrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJamie Webb
\n
Director of Communications and Investor Relations
\n
jwebb@harrowinc.com<\/a>
615-733-4737\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on March 28, 2025 NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["entry","post","publish","author-business","post-60995","format-standard","category-industry"],"yoast_head":"\nHarrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on March 28, 2025 NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-27T15:02:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025\",\"datePublished\":\"2025-03-27T15:02:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/\"},\"wordCount\":268,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250327176398\\\/en\\\/1533746\\\/22\\\/Harrow_logo_wTag.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/\",\"name\":\"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250327176398\\\/en\\\/1533746\\\/22\\\/Harrow_logo_wTag.jpg\",\"datePublished\":\"2025-03-27T15:02:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250327176398\\\/en\\\/1533746\\\/22\\\/Harrow_logo_wTag.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250327176398\\\/en\\\/1533746\\\/22\\\/Harrow_logo_wTag.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend","og_description":"Company to Host Conference Call to Discuss Results at 8:00 a.m. Eastern Time on March 28, 2025 NASHVILLE, Tenn.–(BUSINESS WIRE)–$HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will report its fourth quarter and audited financial results for the year ended December 31, 2024, on Thursday, March 27, 2025, after ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/","og_site_name":"Pharma Trend","article_published_time":"2025-03-27T15:02:36+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025","datePublished":"2025-03-27T15:02:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/"},"wordCount":268,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/","url":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/","name":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg","datePublished":"2025-03-27T15:02:36+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250327176398\/en\/1533746\/22\/Harrow_logo_wTag.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/harrow-to-report-fourth-quarter-and-audited-year-end-2024-financial-results-after-market-close-on-march-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Harrow To Report Fourth Quarter and Audited Year-End 2024 Financial Results After Market Close on March 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60995"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60995\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}